Advertisement
A contraceptive injection for men shows some promise

Male Contraceptive Effective, but Side Effects Problematic

0
Injections as effective as other contraceptives, but side effects prompted early halt of trial
After Roux-en-Y gastric bypass surgery

Study Duration Affects Rate of Diabetes Remission Post-RYGB

0
Differing definitions of remission also account for varied reported remission rates after gastric bypass
In an article published in Medical Economics

Useful Tips Offered for Addressing Negative Patient Reviews

0
Doctors should respond quickly, validate patient complaints, demonstrate willingness to take action
Family socioeconomic status in childhood is associated with the risk for metabolic syndrome and glucose abnormalities in adulthood

Socioeconomic Status in Children Tied to MetS in Adulthood

0
Each unit increase in family SES in childhood linked to decrease in risk for adult metabolic syndrome
For patients with peripheral neuropathic pain

Lower Costs for Pregabalin in Peripheral Neuropathic Pain

0
Even after loss of exclusivity, pregabalin has lower health care costs than gabapentin
Patients with diabetes should do three or more minutes of light activity every 30 minutes during prolonged periods of sitting

New ADA Guidelines Call for More Frequent Activity for DM Patients

0
Light physical activity now recommended every 30 minutes, not every 90 minutes
Governments and international organizations should focus on redressing the balance of ω-6 and ω-3 fatty acids in order to address obesity

Ratio of ω-6:ω-3 Fatty Acids Implicated in Obesity

0
Imbalance, which is typically 16:1 in a Western diet, leads to increased risk of weight gain, inflammation
For patients with type 2 diabetes mellitus

Statins Offset Insulin-Related Cancer Risk in T2DM

0
Risks of cancer reduced with statins; greater risk reduction in those not receiving antihyperglycemic tx
Bariatric surgery not only helps severely obese teens lose weight

Bariatric Surgery May Be Cost-Effective in Severely Obese Teens

0
Long-term clinical trials in adolescents with at least five years of follow-up data needed
Liraglutide increases heart rate and reduces heart rate variability in overweight patients with newly diagnosed type 2 diabetes and stable coronary artery disease

Liraglutide Increases Heart Rate in T2DM With Stable CAD

0
Reduction in heart rate variability despite weight loss and improvement in metabolic parameters